Cubist Systematic Strategies, LLC Y M Abs Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.6 Billion
  • Q1 2025

A detailed history of Cubist Systematic Strategies, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 155,522 shares of YMAB stock, worth $718,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155,522
Previous 48,011 223.93%
Holding current value
$718,511
Previous $375,000 83.47%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$4.43 - $8.17 $476,273 - $878,364
107,511 Added 223.93%
155,522 $688,000
Q4 2024

Feb 14, 2025
BUY
$7.76 - $15.69 $372,565 - $753,292
48,011 New
48,011 $375,000
Q2 2024

Aug 14, 2024
SELL
$11.6 - $17.25 $825,792 - $1.23 Million
-71,189 Reduced 91.52%
6,597 $79,000
Q1 2024

May 15, 2024
BUY
$6.57 - $18.69 $267,228 - $760,197
40,674 Added 109.6%
77,786 $1.26 Million
Q4 2023

Feb 14, 2024
BUY
$4.88 - $7.42 $2,727 - $4,147
559 Added 1.53%
37,112 $253,000
Q3 2023

Nov 14, 2023
SELL
$4.86 - $7.23 $495,695 - $737,423
-101,995 Reduced 73.62%
36,553 $199,000
Q2 2023

Aug 14, 2023
BUY
$5.68 - $10.34 $463,050 - $842,947
81,523 Added 142.96%
138,548 $940,000
Q1 2023

May 15, 2023
BUY
$2.83 - $5.11 $50,560 - $91,295
17,866 Added 45.62%
57,025 $285,000
Q4 2022

Feb 14, 2023
BUY
$3.0 - $15.17 $87,477 - $442,342
29,159 Added 291.59%
39,159 $191,000
Q3 2022

Nov 14, 2022
SELL
$13.96 - $19.67 $7,566 - $10,661
-542 Reduced 5.14%
10,000 $144,000
Q2 2022

Aug 15, 2022
SELL
$8.22 - $15.13 $18,421 - $33,906
-2,241 Reduced 17.53%
10,542 $160,000
Q1 2022

May 16, 2022
BUY
$6.55 - $17.42 $83,728 - $222,679
12,783 New
12,783 $152,000
Q4 2021

Feb 14, 2022
SELL
$15.51 - $29.31 $230,850 - $436,250
-14,884 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$27.47 - $37.31 $408,863 - $555,322
14,884 New
14,884 $425,000
Q1 2021

May 17, 2021
SELL
$29.16 - $51.96 $156,180 - $278,297
-5,356 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$37.86 - $54.26 $202,778 - $290,616
5,356 New
5,356 $265,000
Q3 2019

Nov 14, 2019
SELL
$21.57 - $31.37 $11,216 - $16,312
-520 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$19.51 - $28.31 $10,145 - $14,721
520 New
520 $12,000
Q4 2018

Feb 14, 2019
SELL
$15.41 - $28.92 $32,083 - $60,211
-2,082 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$24.0 - $26.97 $49,968 - $56,151
2,082 New
2,082 $55,000

Others Institutions Holding YMAB

# of Institutions
105
Shares Held
27.1M
Call Options Held
38.4K
Put Options Held
2.1K
View Full List

About Y-mAbs Therapeutics, Inc.

YMAB Quotes by TradingView
  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $202M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email